Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan;6(1):9-17.
doi: 10.1242/dmm.010736.

Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis

Affiliations
Review

Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis

Jonathan A Kropski et al. Dis Model Mech. 2013 Jan.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal lung disease for which there is no known treatment. Although the traditional paradigm of IPF pathogenesis emphasized chronic inflammation as the primary driver of fibrotic remodeling, more recent insights have challenged this view. Linkage analysis and candidate gene approaches have identified four genes that cause the inherited form of IPF, familial interstitial pneumonia (FIP). These four genes encode two surfactant proteins, surfactant protein C (encoded by SFTPC) and surfactant protein A2 (SFTPA2), and two components of the telomerase complex, telomerase reverse transcriptase (TERT) and the RNA component of telomerase (TERC). In this review, we discuss how investigating these mutations, as well as genetic variants identified in other inherited disorders associated with pulmonary fibrosis, are providing new insights into the pathogenesis of common idiopathic interstitial lung diseases, particularly IPF. Studies in this area have highlighted key roles for epithelial cell injury and dysfunction in the development of lung fibrosis. In addition, genetic approaches have uncovered the importance of several processes - including endoplasmic reticulum stress and the unfolded protein response, DNA-damage and -repair pathways, and cellular senescence - that might provide new therapeutic targets in fibrotic lung diseases.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Proposed events underlying IPF pathogenesis. Various genetic factors and environmental exposures act through pathways that converge to produce a ‘vulnerable’ alveolar epithelial cell (AEC) population. Exposure of vulnerable type II AECs to secondary recurrent or persistent injurious stimuli leads to enhanced AEC apoptosis, as well as aberrant activation of developmental programs and stress response pathways, including epithelial-mesenchymal transition (EMT). Ongoing type II AEC dysfunction impairs normal injury-response mechanisms, leading to scar formation and progressive loss of lung architectural complexity. Over time, this culminates in progressive fibrotic remodeling and clinically evident IPF. HPS, Hermansky-Pudlak syndrome.

Similar articles

Cited by

References

    1. Alder J. K., Chen J. J., Lancaster L., Danoff S., Su S. C., Cogan J. D., Vulto I., Xie M., Qi X., Tuder R. M., et al. (2008). Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 105, 13051–13056 - PMC - PubMed
    1. Amin R. S., Wert S. E., Baughman R. P., Tomashefski J. F., Jr, Nogee L. M., Brody A. S., Hull W. M., Whitsett J. A. (2001). Surfactant protein deficiency in familial interstitial lung disease. J. Pediatr. 139, 85–92 - PubMed
    1. Aoshiba K., Tsuji T., Nagai A. (2003). Bleomycin induces cellular senescence in alveolar epithelial cells. Eur. Respir. J. 22, 436–443 - PubMed
    1. Armanios M. (2012). Telomerase and idiopathic pulmonary fibrosis. Mutat. Res. 730, 52–58 - PMC - PubMed
    1. Armanios M., Blackburn E. H. (2012). The telomere syndromes. Nat. Rev. Genet. 13, 693–704 - PMC - PubMed

Publication types

MeSH terms